If US Funding For HIV Programs Is Not Replaced, Millions More Will Die: UN
But in the last six months, the sudden withdrawal of U.S. money has caused a "systemic shock," U.N. officials warned, adding that if the funding isn't replaced, it could lead to more than 4 million AIDS-related deaths and 6 million more HIV infections by 2029.
"The current wave of funding losses has already destabilized supply chains, led to the closure of health facilities, left thousands of health clinics without staff, set back prevention programs, disrupted HIV testing efforts and forced many community organizations to reduce or halt their HIV activities," UNAIDS said in a report released Thursday.
UNAIDS also said that it feared other major donors might also scale back their support, reversing decades of progress against AIDS worldwide - and that the strong multilateral cooperation is in jeopardy because of wars, geopolitical shifts and climate change.
The $4 billion that the United States pledged for the global HIV response for 2025 disappeared virtually overnight in January when U.S. President Donald Trump ordered that all foreign aid be suspended and later moved to shutter the U.S. AID agency.
Andrew Hill, an HIV expert at the University of Liverpool who is not connected to the United Nations, said that while Trump is entitled to spend U.S. money as he sees fit, "any responsible government would have given advance warning so countries could plan," instead of stranding patients in Africa when clinics were closed overnight.
The U.S. President's Emergency Plan for AIDS Relief, or PEPFAR, was launched in 2003 by U.S. President George W. Bush, the biggest-ever commitment by any country focused on a single disease.
UNAIDS called the program a "lifeline" for countries with high HIV rates, and said that it supported testing for 84.1 million people, treatment for 20.6 million, among other initiatives. According to data from Nigeria, PEPFAR also funded 99.9% of the country's budget for medicines taken to prevent HIV.
In 2024, there were about 630,000 AIDS-related deaths worldwide, per a UNAIDS estimate - the figure has remained about the same since 2022 after peaking at about 2 million deaths in 2004.
Even before the U.S. funding cuts, progress against curbing HIV was uneven. UNAIDS said that half of all new infections are in sub-Saharan Africa.
Tom Ellman, of the charity Doctors Without Borders, said that while some poorer countries were now moving to fund more of their own HIV programs, it would be impossible to fill the gap left by the U.S.
"There's nothing we can do that will protect these countries from the sudden, vicious withdrawal of support from the U.S.," said Ellman, director of Doctors Without Borders' South Africa Medical Unit.
Experts also fear another loss: data. The U.S. paid for most HIV surveillance in African countries, including hospital, patient and electronic records, all of which has now abruptly ceased, according to Dr. Chris Beyrer, director of the Global Health Institute at Duke University.
"Without reliable data about how HIV is spreading, it will be incredibly hard to stop it," he said.
The uncertainty comes as a twice-yearly injectable could end HIV, as studies published last year showed that the drug from pharmaceutical maker Gilead was 100% effective in preventing the virus.
At a launch event Thursday, South Africa's health minister Aaron Motsoaledi said the country would "move mountains and rivers to make sure every adolescent girl who needs it will get it," saying that the continent's past dependence upon US aid was "scary."
Last month, the U.S. Food and Drug Administration approved the drug, called Yeztugo, a move that should have been a "threshold moment" for stopping the AIDS epidemic, said Peter Maybarduk of the advocacy group Public Citizen.
But activists like Maybarduk said Gilead's pricing will put it out of reach of many countries that need it. Gilead has agreed to sell generic versions of the drug in 120 poor countries with high HIV rates but has excluded nearly all of Latin America, where rates are far lower but increasing.
"We could be ending AIDS," Maybarduk said. "Instead, the U.S. is abandoning the fight."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
5 hours ago
- Time of India
Eliminating this one food for just 9 days can reduce fatty liver and reverse damage, as per US research findings
People commonly hear warnings about the negative impact of sugary drinks together with processed foods. Scientific studies demonstrate that fructose added to beverages and snacks, creates serious health threats. The sugar causes harm to your liver cells, which could result in serious medical conditions. However, there is good news now! Research reveals that eliminating added fructose for nine days will start to repair damaged liver tissue. Let's dig deeper.... How sugar harms your liver The liver develops fat deposits from fructose consumption which results in nonalcoholic fatty liver disease (NAFLD). Nonalcoholic fatty liver disease (NAFLD) ranks as the leading liver disease among contemporary adults, and impacts approximately 30% of people living in developed nations. NAFLD exists in 90 percent of obese individuals and people with diabetes. Fructose differs from glucose, because it undergoes liver processing to become fat. The presence of liver fat leads to inflammation and causes damage to liver cells, which results in impaired liver operation. The condition results in both insulin resistance and increased risks of developing diabetes and heart disease, and various metabolic disorders. What do studies say Scientists at Touro University and the University of California, San Francisco conducted groundbreaking research with obese Latino and African-American youths who consumed high-fructose diets. The scientists exchanged fructose-rich foods with glucose-rich foods while maintaining the same daily calorie intake. A short period of nine days led to a significant 20% reduction in liver fat, according to MRI results and an enhancement of insulin sensitivity. The participants experienced liver benefits without significant weight changes because their body weight decreased by less than 1%, so the effects were directly related to fructose reduction. Research findings show that NAFLD in its early stages does not need to be permanent, because dietary modifications can reverse the condition within a short period. The culprit? Fructose High-fructose corn syrup (HFCS) found in sodas and processed foods, has led to the increased presence of fructose in modern diets. Research demonstrates that eating large amounts of fructose creates two major health issues, which include fatty liver disease and obesity. The human body processes fructose from processed foods and drinks differently than natural sugars found in whole fruits, because these products contain fewer beneficial compounds such as fiber and antioxidants. The excessive amount of fructose consumption causes liver damage through fat accumulation and metabolic disturbances. Quitting processed sugar When people replace sugary beverages and processed foods with starches and natural foods containing whole sugars, their livers become healthier while decreasing their chances of diabetes and heart disease. Simple dietary changes according to the Touro-UCSF study demonstrate that they can effectively fight against increasing health issues. Practical steps to protect your liver Replace all sugary drinks and sodas with water, herbal tea or natural water infused with fruits. Look for processed foods which contain high-fructose corn syrup and added sugars by checking labels to avoid them in snacks and cereals and sauces. Eat whole foods that contain natural sugars with fiber content, instead of processed foods. Home cooking allows you to maintain control over ingredients and sugar content. Limit your consumption of 100% fruit juices, because their fructose content remains high despite the lack of added sugars. Consult your doctor: If you have obesity, diabetes, or suspect fatty liver disease, seek medical advice early. Sodas and processed foods contain sugar that functions as a hazardous substance, which causes harm to liver tissue and metabolic wellness. Reducing your fructose consumption for a short period allows you to establish both protective measures, and reverse existing liver damage which supports future health. References: UCSF News - Switching Sugar for Starch Leads to Less Fatty Liver in Kids: PMC Article - Effects of Dietary Fructose Restriction on Liver Fat: PMC Article - Effect of a High-Fructose Weight-Maintaining Diet on Liver: UCSF News - Obese Children's Health Rapidly Improves With Sugar Reduction: - Fructose restriction study:
Indian Express
10 hours ago
- Indian Express
‘I had the American dream, but I dropped it': 4 family members share the unseen toll of cancer caregiving in India
Sakshi Agrawal had just finished school – her life was only beginning– when tragedy struck: her father was diagnosed with oral cancer. At 18, she made a decision that would define the next two years – she paused her education to care for him. 'I stayed home to manage his treatment and care. It wasn't just about missing college—it was about putting my entire life on hold,' recallsed Agrawal, now 31. Her brother eventually quit his job and returned home during their father's final months, sacrificing career opportunities in a field with limited prospects locally. Agrawal's story isn't unique. Across India, millions quietly shoulder the exhausting responsibility of caring for loved ones with cancer, often becoming invisible casualties of a disease that demands everything from everyone it touches. In India, where family obligation runs deep, caregiving is rarely seen as a choice; it's an expectation. But the emotional and physical toll this takes on families remains largely unspoken, hidden behind cultural notions of duty and sacrifice. 'I associate one word with caregiving: exhaustion. Bone-crushing exhaustion,' said Saumya Sharma, 31, who cared for her father from 2018 until he passed in 2021, and is now supporting her mother through breast cancer treatment. 'The other one is probably resentment. Resentment with the sick, maybe sometimes, but mostly it is resentment with the situation. No matter what you do as a caregiver, it is never enough. It is as if you stop existing and now only the sick person exists,' she told A 2022 study cited by mental health expert Anjali Pillai, psychologist and programmes lead at SafeStories, Pune, found that two in five caregivers of cancer patients screened positive for depression. Yet, she says, this is just the tip of a crisis hiding in plain sight. For Pavithra Sekar, 28, caring for her mother with stage 3 breast cancer means living in a constant state of vigilance. 'Your brain always has the guard switch on. My mom won't sleep easily, and often she won't say what's bothering her, and we end up in the ER. There are no peaceful nights.' The financial burden is crushing. 'Cancer is a chronic disease, so not all bills are covered by insurance. Surgery and radiation are covered, but chemotherapy and regular medication are not. Medicine alone costs us Rs 20,000 a month,' she said. To manage expenses, Sekar lives on the city's outskirts, enduring a six-hour daily commute to work. The personal toll is just as devastating. 'I've been turned down by men and their families because they fear I'll also get cancer and they won't be able to support us,' she said, adding, 'No one really understands the intensity of cancer.' Sharma's sacrifice was perhaps the most dramatic. After earning admission to an Ivy League MBA programme and working in Boston, she returned to India in 2021 when her father's health declined. 'My company was applying for my H1B, but I dropped the American dream. I don't regret it. I was restless in the US knowing my family was suffering.' Healthcare professionals are witnessing this crisis firsthand. Dr Srinath, senior oncologist and founder at Asha Hospitals, observed that 'caregivers often carry the emotional weight of the diagnosis as heavily as the patient, but with far fewer outlets to express it.' The impact on patient care is direct and measurable. 'When a caregiver's physical or emotional reserves are depleted, it affects their ability to provide consistent and compassionate care. I have seen instances where caregiver exhaustion compromises the accuracy of medication administration or leads to missed follow-ups,' Dr Srinath said. Padma Shri Dr Rajendra A Badwe, chief executive of Tata Cancer Care Foundation and former Director of Tata Memorial Centre, has seen the full spectrum of caregiver experiences: 'Caregivers of cancer patients commonly face a range of challenges. Physically, they often experience fatigue and exhaustion from the demands of caregiving. Emotionally and psychologically, anxiety and depression are common, along with an inability to care for their own needs.' Yet he's also witnessed remarkable resilience. 'Some of them show remarkable courage to face the situation and garner strength to arrange everything so that no stone is unturned in treatment of their loved ones,' he told What makes the caregiver crisis particularly acute in India is the cultural context. For Ayushi Mathur, 37, who has been caring for her mother with metastatic breast cancer since 2018, the challenge is compounded by cultural expectations. 'Sacrifices and hard work are seen as your duty. You're just expected to do it.' Neha Cadabam, senior psychologist at Cadabams Hospitals, said this mindset leaves little space for caregivers to acknowledge their pain. 'Many internalise their distress, fearing it would be seen as selfish or inappropriate,' she said. The trauma can linger long after the crisis ends. 'Many caregivers experience flashbacks, anxiety, or a sense of purposelessness once their role ends,' Cadabam said. A caregiver's state of mind can shape the patient's outlook. 'When caregivers are calm and present, patients feel more secure. If they are distressed, patients can internalise that stress,' said Dr Srinath. Dr Badwe recalled one patient whose husband said, 'When so many good things happened to us, we never asked, 'Why me?'—so why ask now? We will face this together.' Despite the critical role caregivers play, India's healthcare system offers them minimal support. 'At present, India's healthcare system is still deeply focused on the patient, with very little formal support for the caregiver,' noted Dr Srinath. Mathur's experience, too, reflected this gap: 'Unfortunately, this is something that we haven't witnessed yet. While there have been silent acknowledgements of the emotional needs of a caregiver, however, there hasn't been any direct conversation or space given to discuss the emotional needs of caregivers.' Left to their own devices, caregivers develop whatever coping mechanisms they can. Sharma, dealing with the complex emotions of caring for someone with whom she had a 'difficult relationship,' sought therapy while in the US. 'I had a difficult relationship with my father, and when I was in the US, I took therapy to process how I was feeling about his deteriorating condition,' she said. 'To cope, I do meditation whenever I can. I also write and try my best to go to the gym. I also consume marijuana gummies from time to time when I feel a lot of stress,' Sharma said. Agrawal's struggle continues years later. 'That uncertainty, never knowing how he'd be the next day, or what news we'd get, weighed on me constantly. It was emotionally exhausting. I didn't know how to process what I was feeling at the time, and honestly, even today, I struggle. I find it hard to open up or feel emotionally comfortable around people,' she said. Caregivers often only process their trauma years later. Sharma fell into depression three years after her father's death. 'During the illness, you live in survival mode,' she said. Pillai said this is common: 'Even after recovery or loss, many live as though the next crisis is just around the corner.' Experts call for systemic reform. Dr Badwe recommended patient navigation services, distress assessment tools, and AI-enabled coping apps for caregivers. Pillai said, 'Hospitals must integrate routine mental health check-ins and provide on-site counsellors.' As India grapples with rising cancer rates—with over 1.4 million new cases diagnosed annually—the army of invisible caregivers continues to grow. These family members are sacrificing their careers, health, and happiness to fill the gaps in a healthcare system that hasn't yet learned to see them.
&w=3840&q=100)
Business Standard
10 hours ago
- Business Standard
These biomarkers may predict organ failure, death in chronic kidney disease
A new study highlights biomarkers that may predict chronic kidney disease progression, opening new possibilities for targeted care and personalised medicine New Delhi If you or someone close to you is living with chronic kidney disease (CKD), doctors may soon have new ways to predict who is most likely to face kidney failure or early death. Researchers in the UK have found that certain biomarkers can indicate whether CKD patients are at higher risk of kidney failure or death. These results, cited in the Journal of the American Society of Nephrology in the study 'Biomarkers of Kidney Failure and All-Cause Mortality in CKD', highlight the new possibilities of personalised treatment. The study was led by researchers at the University of Surrey as part of the National Unified Renal Translational Research Enterprise (NURTuRE) CKD study and funded by Kidney Research UK. It analysed data from 2,884 adults with CKD across 16 UK nephrology centres. What is chronic kidney disease and why is it dangerous? According to Cleveland Clinic, an American nonprofit academic medical center, chronic kidney disease is a long-term condition where the kidneys slowly lose their ability to filter waste and excess fluids from the blood. It affects millions worldwide and often leads to serious complications like kidney failure, heart disease, and even early death. What did the study find? The researchers studied 21 biomarkers linked to kidney damage, fibrosis, inflammation, and cardiovascular stress. Out of these, some combinations stood out as strong predictors: For kidney failure: soluble TNF receptor 1 (sTNFR1), soluble CD40 (sCD40), and urinary collagen type 1 a1 chain (UCOL1A1). For all-cause mortality: high-sensitivity cardiac troponin T (hs-cTnT), N-terminal pro-brain natriuretic peptide (NT-proBNP), and soluble urokinase plasminogen activator receptor (suPAR). These biomarkers reflect different disease mechanisms like inflammation, cardiovascular strain, and tissue damage, helping paint a fuller picture of CKD progression. Dr Tony Onoja, lead author and research fellow at the University of Surrey, explained in a statement published on the university website, "Our research shows that these biomarker models offer predictive results comparable to established methods, but more importantly, they help us understand how the disease progresses. This could open the door to personalised treatments in the future." Professor Nophar Geifman, senior author of the study, added, "Specific biomarkers can give a more nuanced understanding of a patient's disease progression and mortality risk. Further research is needed to explore how these markers respond to treatments and how they can be integrated into clinical care." How can these biomarkers change future CKD treatments? According to the researchers, by identifying patients most at risk of kidney failure or early death, doctors may: Monitor disease progression more closely Develop personalised treatment strategies Test new targeted therapies that address inflammation, fibrosis, or cardiovascular stress Although more clinical validation is needed, these findings point towards a future where CKD management is far more personalised than it is today.
